Related Experiment Video

Updated: Feb 28, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.7K

Beam Me In: Thyroid Hormone Analog Targets Alternative Transporter in Mouse Model of X-Linked Adrenoleukodystrophy

Anna Milanesi1, Gregory A Brent1

  • 1Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, and Endocrinology Division, Departments of Medicine and Physiology, David Geffen School of Medicine at UCLA, Los Angeles, California 90073

Endocrinology
|June 15, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.3K
Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
04:05

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse

Published on: October 6, 2023

818

Related Experiment Videos

Last Updated: Feb 28, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.7K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.3K
Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
04:05

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse

Published on: October 6, 2023

818

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56

Articles linked to this work by shared authors, journal, and citation graph.

Beyond hormone deficiency: a framework for endocrine-immune-niche integration in aging skeletal muscle regeneration.

Frontiers in immunology·2026

Hypothyroidism impairs skeletal muscle regeneration after injury by altering myogenic and nonmyogenic pathways.

JCI insight·2026

Autoimmune Thyroid Disease in the United States: Population Prevalence, Diagnosis Rates, and Trends.

Journal of the Endocrine Society·2025

Thyroxine Treatment after Traumatic Brain Injury Suppresses Astrogliosis and Enhances Neuronal Recovery in Mice.

Thyroid : official journal of the American Thyroid Association·2025

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association·2025

A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024

GHRH and GLP-1 receptor agonism promote human β-cell survival and improve glucose homeostasis in diabetic mice.

Endocrinology·2026

miR-483 deficiency promotes loss of pancreatic beta-cell identity and aberrant glucagon production under metabolic stress.

Endocrinology·2026

Free fatty acid receptor 4 agonism stimulates insulin secretion via different mechanisms in mouse versus human islets.

Endocrinology·2026

Critical Function of SIK3 in Androgen-Producing Ovarian Theca Cells for Female Reproductive Competence.

Endocrinology·2026

ATP-dependent chromatin remodelers in prostate cancer progression and therapeutic resistance.

Endocrinology·2026

Tagln1-Cre driven Ercc1 deficiency reveals sex specific effects on adipose tissue in mice.

Endocrinology·2026

New FDA-Approved Treg Therapy to Reduce Chronic GVHD After Allogeneic HSCT.

Blood·2026

Zinc ion-releasing immunomodulatory hydrogels for enhanced wound healing.

Regenerative biomaterials·2026

Correction: TGFB2-mediated regeneration of pelvic ligament equivalents using a stem cell-fibroblast-decellularized membrane composite.

Frontiers in bioengineering and biotechnology·2026

Multifunctional pH-responsive HA-c-FZ1 hydrogel presents a promising therapeutic strategy for diabetic skin wounds.

Burns & trauma·2026

Correction: Characterization of the roles of amphiregulin and transforming growth factor β1 in microvasculature-like formation in human granulosa-lutein cells.

Frontiers in cell and developmental biology·2026

Stronger Together: Isograft Fusion Accelerates Recovery and May Facilitate Heat-Evolved Symbiont Transmission in Bleached Adult Corals.

Environmental microbiology reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us